News

Calcium Supplements Tied to Higher MI Risk


 

From the Annual Meeting of the American Society for Bone and Mineral Research

When the Auckland researchers added the results from the WHI subanalysis to their previously reported meta-analysis, they “just reinforced the trends and made them more significant,” Dr. Reid said in an interview.

When data from the WHI subgroup that did not use personal calcium supplements at baseline were added to the meta-analysis, the results showed that those who did take supplements had a 24% relative excess of MIs, a 15% relative excess of stroke, and a 16% relative excess of MI or stroke, he reported.

“What we now have is six or seven very large trials, and [the results they show] for myocardial infarction all line up very consistently, without significant heterogeneity. When you look at risk vs. benefit, the evidence for an increased risk of myocardial infarction is stronger than the evidence that calcium supplements prevent bone fractures. It's hard to justify continuing calcium supplements,” Dr. Reid said.

The evidence for an increased MI risk is stronger than the evidence that supplements prevent bone fractures.

Source DR. REID

There are concerns about 'whether omitting the subgroups with favorable results is appropriate.'

Source DR. MANSON

Pages

Recommended Reading

Agency Cautions on PPI-Related Vulnerabilities
MDedge Endocrinology
Fracture Risk Spikes With Thiazolidinediones
MDedge Endocrinology
Femur Fractures May Be Tied to Bisphosphonates
MDedge Endocrinology
Oral Bisphosphonates Not Linked to Esophageal, Gastric Ca
MDedge Endocrinology
Prompt Vertebroplasty Eased Acute Fracture Pain
MDedge Endocrinology
Bone Hormone May Predict Mortality in HF
MDedge Endocrinology
Six-Year Zoledronic Acid Regimen Safe, Effective
MDedge Endocrinology
BMD at Bisphosphonate's End Predicts Fractures
MDedge Endocrinology
Teriparatide Prompted 29% Gain in Alveolar Bone
MDedge Endocrinology
FDA Warns of Atypical Fractures Linked to Bisphosphonates
MDedge Endocrinology